China: A recent study published in BMC Urology highlighted PSA density (PSAD) as an effective predictor of prostate cancer in ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from ...

Teleflex (NYSE: TFX) today announced new data highlighting the success of its UroLift benign prostatic hyperplasia (BPH) ...

Sri Ramakrishna Hospital's Urology experts share information about the Holmium Laser prostate Surgery that has been highly ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation ...

UCL,child penalty,diagnosisHere are the top medical news for the day:Study Highlights 10% Earnings Decline in Women Four ...

Using a high-pressure water jet to operate on an enlarged prostate can better preserve the ability to ejaculate, compared ...

Use of nationwide medical registries allowed long and virtually complete follow-up. Initiators of glucose-lowering drugs (GLDs) could be identified in a calendar period in which both metformin and ...

Dr. Naveen M N discusses significant prostate health issues: benign prostatic hyperplasia (BPH), prostatitis, prostate stones ...

Glucagon-like peptide-1 agonist weight loss medications decrease sexual desire: a theoretical framework based in the serotonergic pathway - (https://academic.oup.com/jsm) ...

Treatment with finasteride alone produced a 50% reduction in the relative risk of patients with symptomatic BPH developing these problems. [5] This was the rationale for the Medical Therapy of ...